𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Maintenance therapy in nonsmall-cell lung cancer : A new treatment paradigm

✍ Scribed by Tony S. K. Mok; Suresh S. Ramalingam

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
173 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line treatments after first-line
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
✍ Jenn-Yu Wu; Jin-Yuan Shih; Chih-Hsin Yang; Kuan-Yu Chen; Chao-Chi Ho; Chong-Jen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 236 KB

## Abstract Gefitinib is effective as first‐line therapy for advanced nonsmall cell lung cancer (NSCLC). However, after failure of gefitinib, it is unknown whether any second‐line regimens could lead to better outcomes. To study the influence of different second‐line antitumor regimens on the outco

Treatment of small cell lung cancer: Int
Treatment of small cell lung cancer: Intensive remission induction, radiation therapy, and maintenance chemotherapy
✍ Bezwoda, W. R. ;Derman, D. P. ;de Moor, N. G. ;Kallenbach, J. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

## Abstract Forty‐eight patients with small cell lung cancer were treated with an intensive therapy regimen which included induction chemotherapy with vincristine, adriamycin, procarbazine, and methotrexate. This was followed by radiation therapy given to areas of residual disease after restaging.

Positron emission tomography imaging in
Positron emission tomography imaging in nonsmall-cell lung cancer
✍ Jeremy J. Erasmus; Homer A. Macapinlac; Stephen G. Swisher 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

## Abstract Positron emission tomography (PET) using 18F‐2‐deoxy‐D‐glucose, a D‐glucose analog labeled with fluorine‐18, complements conventional radiologic assessment in the evaluation of patients with nonsmall‐cell lung cancer (NSCLC). PET is being routinely used to improve the detection of nodal

A novel KIF5B-ALK variant in nonsmall ce
A novel KIF5B-ALK variant in nonsmall cell lung cancer
✍ Daisy Wing-Sze Wong; Elaine Lai-Han Leung; Sunny Kit-Man Wong; Vicky Pui-Chi Tin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

## Abstract ## BACKGROUND: The anaplastic lymphoma kinase (__ALK__) gene is involved frequently in chromosomal translocations, resulting in fusion genes with different partners found in various lymphoproliferative conditions. It was recently reported in nonsmall cell lung cancer (NSCLC) that the f

The value of combined-modality therapy i
The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer
✍ Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phil 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to assess the value of combined‐modality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l